logo-loader
NASDAQ:SNGX

Soligenix Inc

Receive alerts
Market:
NASDAQ
Price
0.24 USD
Day Change
-5.02%
Market Cap:
$5.91 m
52 weeks high
1.69
52 weeks low
0.24

In brief

Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.

The company has two areas of focus:

  1. a specialized biotherapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need such as cutaneous T-cell lymphoma, psoriasis, oral mucositis, and Behçet’s Disease.
  2. a public health solutions segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure and viral disease including Ebola, Marburg and COVID-19.